What medication regimen should be prescribed for a patient with acute mania admitted to a crisis unit for bipolar disorder?

Recommended Initial Treatment for Acute Mania on Crisis Unit Admission

Start with either lithium, valproate, or an atypical antipsychotic (olanzapine, risperidone, aripiprazole, or quetiapine) as monotherapy, and immediately discontinue any ongoing antidepressant medication. 1, 2, 3

First-Line Monotherapy Options

The evidence consistently supports these medications as initial treatment:

Traditional Mood Stabilizers:

• Lithium - Well-established efficacy with strong evidence base
• Valproate (divalproex) - Particularly effective, with some guidelines favoring it for mixed episodes 2, 3

Atypical Antipsychotics (preferred for rapid control):

• Olanzapine (15-20 mg/day) - Robust efficacy data 4, 5, 6
• Risperidone (3-4 mg/day) - Excellent efficacy profile 4, 5, 6
• Aripiprazole (15 mg/day) - Well-tolerated option 4, 6
• Quetiapine - Effective with good tolerability 5, 6
• Ziprasidone (160 mg/day) - Strong efficacy evidence 4, 5

When to Escalate to Combination Therapy

If monotherapy proves insufficient within 3-7 days, combine a traditional mood stabilizer (lithium or valproate) with an atypical antipsychotic. 2, 3 This combination approach is recommended as second-line treatment, though some guidelines suggest it as first-line for severe mania 2, 3.

Recent network meta-analysis data shows that combination therapies (antipsychotics + lithium/valproate) demonstrate superior efficacy compared to their corresponding monotherapies 5. Notably, tamoxifen combined with lithium or valproate showed exceptional efficacy (SMD = -16.37), though this requires further validation 5.

Managing Acute Agitation in the Crisis Setting

For patients presenting with severe agitation requiring immediate control 1:

Parenteral Options (Level B recommendations):

• Haloperidol (5-8 mg IM) - conventional but effective
• Lorazepam (2 mg IM) - benzodiazepine monotherapy
• Combination: Haloperidol + lorazepam may produce more rapid sedation than monotherapy (Level C) 1

Oral Options for Cooperative Patients:

• Combination of oral lorazepam + oral risperidone for agitated but cooperative patients 1

Critical Action Items

Immediately discontinue antidepressants - All guidelines unanimously agree on stopping ongoing antidepressant medication during manic phases, as they can worsen or prolong the episode 2, 3.

Medication-Specific Considerations

Carbamazepine - Generally relegated to second-line treatment and not recommended in combination therapy 2, 3

Other antiepileptics - Not recommended for acute mania treatment, though lamotrigine may be continued if previously prescribed for depression prevention 3

Common Pitfalls to Avoid

• Don't continue antidepressants - This is universally contraindicated during mania
• Don't delay treatment - Acute mania requires prompt pharmacological intervention
• Don't use monotherapy indefinitely if ineffective - Escalate to combination therapy within one week if inadequate response
• Don't overlook mixed features - Some evidence suggests valproate or carbamazepine may be preferable to lithium for mixed episodes, though this remains debated 2

Treatment-Refractory Cases

For patients not responding to standard approaches, consider 6:

• Clozapine - Evidence supports use in refractory mania
• Electroconvulsive therapy (ECT) - Effective for treatment-resistant cases

Practical Algorithm

1. Assess severity and agitation level
2. If severely agitated: Use parenteral haloperidol ± lorazepam for immediate control 1
3. Simultaneously initiate: Lithium, valproate, or atypical antipsychotic as definitive treatment
4. Stop all antidepressants immediately
5. Reassess at 3-7 days: If insufficient response, add second agent (mood stabilizer + antipsychotic combination)
6. If still refractory: Consider clozapine or ECT 6

The choice between mood stabilizers and antipsychotics as initial monotherapy depends on the clinical presentation: antipsychotics may offer faster symptom control, while mood stabilizers provide better long-term prophylaxis. For crisis unit admissions where rapid stabilization is paramount, atypical antipsychotics often represent the most practical first choice given their faster onset of action.